Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Phase II/Phase III Study of Adjuvant Concurrent Radiation and Chemotherapy Versus Radiation Alone in Resected High-Risk Malignant Salivary Gland Tumors

NCT01220583 is registered in ClinicalTrials.gov with Radiation Therapy Oncology Group as lead sponsor.

NCT NCT01220583
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01220583 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Phase II/Phase III Study of Adjuvant Concurrent Radiation and Chemotherapy Versus Radiation Alone in Resected High-Risk Malignant Salivary Gland Tumors
Lead sponsor
Radiation Therapy Oncology Group
Phase
Phase 2
Overall status
Active, not recruiting
Start date
January 31, 2011
Completion date
October 31, 2028
Enrollment
252 (actual)
Sites
268

Conditions

As the registry lists them; a condition with its own page is linked.

head and neck cancer